ARCHIVES

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

ORI Finds St. Mary’s Data Managers Falsified Data In BCPT

September 8, 1995

Turnover In Immunology Contracts To Free Up Substantial Sums, Possible New RFPs Listed

October 8, 1976

Judge Rules Privacy Act Not Applicable In Bernard Fisher’s Suit Against HHA

July 5, 1996

Regulatory Agencies: Groups Petition FDA To Ease Silicone Gel Implant Restrictions

September 27, 1996

Hughes institute Considers More Support For Genome Mapping

August 1, 1986

High Vitamin E Consumption Can Lower Liver Cancer Risks

July 27, 2012